These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6254017

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M.
    Cancer Res; 1995 Aug 15; 55(16):3675-81. PubMed ID: 7627978
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cytotoxic T cells from a human chimera induce regression of Epstein-Barr virus-infected allogeneic host cells.
    Plotnicky H, Touraine JL.
    Int Immunol; 1993 Nov 15; 5(11):1413-20. PubMed ID: 8260455
    [Abstract] [Full Text] [Related]

  • 28. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
    Rooney CM, Rickinson AB, Moss DJ, Lenoir GM, Epstein MA.
    IARC Sci Publ; 1985 Nov 15; (60):249-64. PubMed ID: 2998992
    [Abstract] [Full Text] [Related]

  • 29. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.
    Lipinski M, Fridman WH, Tursz T, Vincent C, Pious D, Fellous M.
    J Exp Med; 1979 Dec 01; 150(6):1310-22. PubMed ID: 229186
    [Abstract] [Full Text] [Related]

  • 30. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
    Khanna R, Burrows SR, Nicholls J, Poulsen LM.
    Eur J Immunol; 1998 Feb 01; 28(2):451-8. PubMed ID: 9521052
    [Abstract] [Full Text] [Related]

  • 31. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct 01; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

  • 32. Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C molecules.
    Chen BP, Lam V, Kraus EE, DeMars R, Sondel PM.
    Hum Immunol; 1989 Oct 01; 26(2):137-47. PubMed ID: 2479624
    [Abstract] [Full Text] [Related]

  • 33. Expression of target antigen for Epstein-Barr virus-specific cytotoxic T cells on BJAB cells freshly infected with EBV.
    Sugamura K, Tanaka Y, Hinuma Y.
    Microbiol Immunol; 1982 Oct 01; 26(7):575-83. PubMed ID: 6290853
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ, Wallace LE, Rickinson AB, Epstein MA.
    Eur J Immunol; 1981 Sep 01; 11(9):686-93. PubMed ID: 6170517
    [Abstract] [Full Text] [Related]

  • 35. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
    Plotnicky H, Touraine JL.
    Clin Exp Immunol; 1993 Dec 01; 94(3):494-9. PubMed ID: 7504600
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen.
    Wallace LE, Rickinson AB, Rowe M, Epstein MA.
    Nature; 1982 Jun 03; 297(5865):413-5. PubMed ID: 6176881
    [No Abstract] [Full Text] [Related]

  • 37. Factors influencing the human cytotoxic T cell response to autologous lymphoblastoid cell lines in vitro.
    Misko IS, Soszynski TD, Kane RG, Pope JH.
    Clin Immunol Immunopathol; 1984 Sep 03; 32(3):285-97. PubMed ID: 6088142
    [Abstract] [Full Text] [Related]

  • 38. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
    Torsteinsdottir S, Masucci MG, Szigeti R, Bishara A, Brautbar C, Klein G, Klein E.
    Mol Biol Med; 1984 Aug 03; 2(4):285-99. PubMed ID: 6443579
    [Abstract] [Full Text] [Related]

  • 39. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR, Silins SL, Khanna R, Burrows JM, Rischmueller M, McCluskey J, Moss DJ.
    Eur J Immunol; 1997 Jul 03; 27(7):1726-36. PubMed ID: 9247584
    [Abstract] [Full Text] [Related]

  • 40. Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Chen BP, DeMars R, Sondel PM.
    Hum Immunol; 1987 Jan 03; 18(1):75-91. PubMed ID: 3542914
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.